More on PEBK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-6.9% Growth)
- Holders
- Dividends (2% Yield)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (1/22/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PEBK Cash Flow Statement

Click line-items for a historical chart and %
Net earnings 7.88M
Depreciation, amortization and accretion 4.18M
Provision for loan losses -1.11M
Gain on sale of investment securities -324K
Write-down of investment securities 17K
Loss/(Gain) on sale of other real estate and repossessions -81K
Write-down of other real estate and repossessions
Restricted stock expense 476K
Mortgage loans held for sale
Cash surrender value of life insurance -307K
Other assets 897K
Other liabilities 49K
Net cash provided by operating activities 12.44M
Net change in certificates of deposit
Purchases of investment securities available for sale -12.64M
Proceeds from calls, maturities and paydowns of investment securities available for sale 2.9M
Proceeds from sale of investment securities available for sale 15.95M
Purchases of other investments
Proceeds from sale of other investments
Net change in loans -24.64M
Purchases of premises and equipment -1.26M
Proceeds from sale of other real estate and repossessions 1.05M
Net cash provided (used) by investing activities -18.64M
Net change in deposits 29.77M
Net change in demand notes payable to U.S. Treasury
Net change in securities sold under agreement to repurchase 23.05M
Proceeds from FHLB borrowings 0
Repayments of FHLB borrowings 0
Restricted stock payout
Cash dividends paid on Series A preferred stock
Cash dividends paid on common stock -1.56M
Net cash provided by financing activities 49.28M
Net change in cash and cash equivalent 43.08M
Cash and cash equivalents at beginning of period 39.76M
Cash and cash equivalents at end of period 82.84M
Interest 2.43M
Income taxes 3.18M
Change in unrealized gain on investment securities available for sale, net 1.45M
Change in unrealized gain on derivative financial instruments, net
Transfer of loans to other real estate and repossessions 275K
Financed portion of sale of other real estate
Accretion of Series A preferred stock